2025 - Introduced
Kentucky S.B.128
  • Prohibits Medicaid from denying coverage for a non-opioid in favor of an opioid or establishing more restrictive or extensive utilization controls for non-opioids than the least restrictive or extensive utilization controls for any opioid.
Medicaid Parity
Read Bill
2024 - Passed
Louisiana S.B. 224
  • Directs that the state Medicaid program may not impose more restrictive utilization controls for non-opioid drugs than for opioids.
  • Prohibits Medicaid managed care organizations from denying coverage for a non-opioid prescription prescribed for pain in favor of an opioid.
  • Directs the state to create education, awareness and technical assistance materials on the advantage of non-opioid drugs and provide assistance with grants that promote non-opioid pain drugs.
EducationMedicaid Parity
Read Bill
2024 - Passed
Maine L.D. 2096
  • Requires health insurers develop and submit a plan to the Maine Bureau of Insurance for review and approval of the inclusion of non-opioid pain management services and treatments. Upon approval, insurers must develop and disseminate related educational materials.
State Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Maryland H.B. 1013/S.B. 974
  • Prohibits prior authorization requirements, step therapy protocol, or fail-first protocol for a non-opioid that is more restrictive than requirements for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Massachusetts H.1134/S.863
  • Mandates Medicaid from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs. The bill also creates a comprehensive integrated care management strategy for chronic pain patients enrolled in Medicaid and requires the Center for Health Information & Analysis to issue a report every two years on the incidence and prevalence of chronic pain in Massachusetts.
Medicaid Parity
Read House BillRead Senate Bill
2024 - Passed
Massachusetts H.5142
  • Requires health insurers to cover non-opioid medications without favoring opioids over non-opioids.
  • Requires the Massachusetts Department of Health create educational materials about non-opioid treatments for use at pharmacies, as well as develop new provider training requirements regarding non-opioid alternatives for pain treatment.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Minnesota S.F. 1946/H.F. 1806
  • Requires health insurers cover non-opioid treatments and prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids. Also requires health insurers to distribute non-opioid educational materials to in-network providers and enrollees and to publish resources on the health plan company's website.
State Regulated Commercial ParityProvider Education
Read Senate BillRead House Bill
2025 - Introduced
Minnesota S.F. 1947/H.F. 1807
  • Requires that in establishing and maintaining Minnesota's preferred drug list, health insurers must not disadvantage or discourage a non-opioid drug with respect to coverage of an opioid drug.
Medicaid Parity
Read Senate BillRead House Bill
2025 - Introduced
Mississippi H.B.1389
  • Prohibits practices that disadvantage or discourage the use of non-opioid drugs relative to opioids in state Medicaid program.
Medicaid Parity
Read Bill
2025 - Introduced
Missouri S.B.158/H.B. 804
  • For enrollees with an increased risk of opioid abuse, prohibits health insurers from: (1) denying coverage for non-opioid prescription drugs in favor of opioid drugs; (2) requiring an enrollee try an opioid prescription drug prior to approving the use of a non-opioid prescription drug; or (3) requiring a higher cost-sharing for non-opioid prescription drugs.
State Regulated Commercial Parity
Read Senate BillRead House Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B. 252
  • Directs the Nebraska Health and Human Services Committee of the Legislature to create a study to examine non-opioid treatment options in Medicaid.
Pain Study
Read Bill